Qube Research & Technologies (QRT)
HEPA

Qube Research & Technologies (QRT)’s Hepion Pharmaceuticals HEPA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16
Closed -$25K – 2709
2021
Q3 		$25K Buy
+16
New +$25.6K ﹤0.01% 1953

Other funds holding HEPA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HEPA Position: Q4 2021 in Review

Qube Research & Technologies (QRT) sold out of Hepion Pharmaceuticals (HEPA) in Q4 2021, closing a stake of 16 shares — an estimated $25K sold.

Qube Research & Technologies (QRT) first reported a position in HEPA in Q3 2021 and held it in 1 quarter. The position peaked at $25K in Q3 2021. 39 funds tracked by Wall St. Rank hold HEPA as of Q4 2021.

  • Qube Research & Technologies (QRT) reported no remaining Hepion Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 16 Hepion Pharmaceuticals shares in Q4 2021, an estimated $25K.
  • Qube Research & Technologies (QRT) first reported a position in Hepion Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Hepion Pharmaceuticals position peaked at $25K in Q3 2021.
  • 39 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q4 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2021, filed 1 Feb 2022.